IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.789
EU - Europa 25.820
AS - Asia 15.520
SA - Sud America 2.751
Continente sconosciuto - Info sul continente non disponibili 946
AF - Africa 450
OC - Oceania 38
Totale 72.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.103
RU - Federazione Russa 7.041
IE - Irlanda 5.575
SG - Singapore 4.888
CN - Cina 3.656
DE - Germania 2.938
HK - Hong Kong 2.926
SE - Svezia 2.683
UA - Ucraina 2.214
BR - Brasile 2.085
IT - Italia 1.889
VN - Vietnam 1.841
FI - Finlandia 1.194
FR - Francia 956
GB - Regno Unito 591
IN - India 480
BD - Bangladesh 446
KR - Corea 337
CA - Canada 333
AR - Argentina 259
MX - Messico 196
ID - Indonesia 152
ZA - Sudafrica 140
NL - Olanda 120
EC - Ecuador 109
PL - Polonia 109
JP - Giappone 107
IQ - Iraq 106
BJ - Benin 103
TR - Turchia 91
ES - Italia 90
CO - Colombia 83
AT - Austria 76
EU - Europa 70
IR - Iran 70
VE - Venezuela 67
BE - Belgio 61
CZ - Repubblica Ceca 56
LT - Lituania 55
PK - Pakistan 52
PY - Paraguay 50
CL - Cile 40
SA - Arabia Saudita 39
EG - Egitto 35
JM - Giamaica 35
MY - Malesia 35
MA - Marocco 32
PH - Filippine 32
KE - Kenya 31
UZ - Uzbekistan 31
DZ - Algeria 30
PE - Perù 30
AU - Australia 27
MD - Moldavia 26
SY - Repubblica araba siriana 26
CR - Costa Rica 24
TN - Tunisia 21
BG - Bulgaria 18
IL - Israele 18
TW - Taiwan 18
JO - Giordania 17
RO - Romania 17
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
ET - Etiopia 16
KZ - Kazakistan 15
TT - Trinidad e Tobago 15
DO - Repubblica Dominicana 14
TH - Thailandia 14
UY - Uruguay 14
AZ - Azerbaigian 13
NP - Nepal 13
AL - Albania 12
OM - Oman 12
DK - Danimarca 11
HN - Honduras 11
KG - Kirghizistan 10
LB - Libano 10
RS - Serbia 10
BO - Bolivia 9
HR - Croazia 9
NI - Nicaragua 9
NZ - Nuova Zelanda 9
PA - Panama 9
SV - El Salvador 9
GR - Grecia 8
NG - Nigeria 8
PT - Portogallo 8
BB - Barbados 7
BH - Bahrain 7
CI - Costa d'Avorio 6
CY - Cipro 6
GE - Georgia 6
GT - Guatemala 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
AO - Angola 5
HU - Ungheria 5
MK - Macedonia 5
PR - Porto Rico 5
Totale 71.350
Salva come PNG Salva come JPEG
Città #
Dublin 5.559
Jacksonville 3.939
Hong Kong 2.918
San Jose 2.344
Singapore 2.065
Dearborn 1.872
Council Bluffs 1.570
Ashburn 1.525
Chandler 1.334
Wilmington 1.283
Beijing 1.082
Moscow 948
Lawrence 733
Princeton 733
Lauterbourg 710
Los Angeles 624
Ho Chi Minh City 588
San Mateo 564
Hanoi 403
Buffalo 398
Andover 379
Piemonte 371
Columbus 353
Seoul 315
Boardman 314
Ann Arbor 301
New York 283
Santa Clara 270
Houston 229
São Paulo 207
Woodbridge 200
Dallas 199
Novara 166
Orem 157
Hefei 145
Munich 143
Redondo Beach 142
Philadelphia 133
Frankfurt am Main 122
Guangzhou 117
Düsseldorf 115
Milan 115
Helsinki 112
Nanjing 112
Mexico City 111
Cotonou 103
Bremen 102
Kunming 98
Atlanta 93
Chennai 93
Montreal 92
Norwalk 92
Toronto 92
Chicago 90
Tokyo 90
Warsaw 90
London 87
Denver 83
Nuremberg 82
Da Nang 80
Grafing 80
Tianjin 80
Brooklyn 78
Haiphong 74
Johannesburg 74
Phoenix 74
Rome 73
St Louis 73
Hangzhou 67
Rio de Janeiro 66
Turin 64
Poplar 63
Falkenstein 61
Seattle 59
Stockholm 55
Brussels 54
Jinan 54
Manchester 54
Amsterdam 53
Fairfield 53
San Bernardino 51
Mumbai 47
Shanghai 47
Belo Horizonte 45
Curitiba 45
San Francisco 45
Nanchang 42
Boston 41
Brno 41
Jakarta 41
Vercelli 40
Brasília 39
Quito 37
Biên Hòa 36
Guayaquil 35
Las Vegas 35
Vienna 35
Porto Alegre 34
Baghdad 32
Dhaka 32
Totale 39.779
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 241
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 238
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers 221
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 204
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 199
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 184
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 183
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 181
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 180
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 179
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 178
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 176
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 167
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 160
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 160
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 154
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 154
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 152
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 149
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 149
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 148
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 147
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 147
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 147
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 146
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 143
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 143
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 142
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 142
Targeting p53 in chronic lymphocytic leukemia 142
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 141
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 140
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 140
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 140
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 139
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 139
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 139
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 138
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 138
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 138
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 137
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 136
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 136
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 136
The clinical implications of gene mutations in chronic lymphocytic leukaemia 136
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 136
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 136
Factor VIII as a potential player in cancer pathophysiology 136
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 135
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 135
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 135
Absence of NOTCH1 gene mutations in MALT lymphomas 134
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 134
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 133
DIAGNOSI E CLASSIFICAZIONE DEI LINFOMI NON-HODGKIN. BASI PATOLOGICHE, FENOTIPICHE E MOLECOLARI 132
Libro universitario: Letteratura, medicina e scienze sociali. Convergenze tra culture e linguaggi; Chapter- Per un’etica della condivisione dei benefici in tema di sperimentazione dei farmaci 132
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 131
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 130
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 130
The genetics of nodal marginal zone lymphoma 129
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 128
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 127
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 127
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 127
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 127
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 127
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 127
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 127
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 126
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 126
Chronic lymphocytic leukaemia: a step ahead in the journey toward eradication 126
Biology and treatment of Richter syndrome 126
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 126
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 126
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 125
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo 125
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 125
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 125
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 125
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 125
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 124
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 124
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 124
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 123
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 123
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 123
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 122
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 122
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 122
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 122
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 121
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 121
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 121
European education corridors: opportunity for academic solidarity 121
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 120
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group 120
TAQI RFLP IN THE INTERFERON GAMMA RECEPTOR 1 GENE (IFNGR1) ON HUMAN CHROMOSOME 6q 120
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 120
Totale 14.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 376.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 376.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.874 0 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/202627.253 1.029 893 2.116 3.717 1.947 2.021 4.094 4.696 2.289 2.232 1.450 769
2026/20273.010 1.132 1.878 0 0 0 0 0 0 0 0 0 0
Totale 72.314